nab-paclitaxel at a dose of 125 mg/m(2) weekly is more efficacious but less toxic than at 150 mg/m(2) : Results from the neoadjuvant randomized GeparSepto study (GBG 69)

Authors :: Untch, M.
von Minckwitz, G.
Jackisch, C.
Schneeweiss, A.
Conrad, B.
Aktas, B.
Denkert, C.
Eidtmann, H.
Wiebringhaus, H.
Kuemmel, S.
Hilfrich, J.
Warm, M.
Paepke, S.
Just, M.
Hanusch, C.
Hackmann, J.
Blohmer, J. Uwe
Clemens, M.
Costa, S. Dan
Gerber, B.
Nekljudova, V.
Loibl, S.
Publication Year :: 2016
Abstract: Poster-Abstract

Tools